Peter Conti
Impact in
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Monoclonal and Polyclonal Antibodies Research
Papers in
-
- Radiopharmaceutical Chemistry and Applications 11
- Medical Imaging Techniques and Applications 8
- Radiomics and Machine Learning in Medical Imaging 5
- Monoclonal and Polyclonal Antibodies Research 2
-
- Prostate Cancer Treatment and Research 4
- Medical Imaging and Pathology Studies 2
- Co-authors
- Hossein Jadvar (3 shared papers)James R. Bading (2 shared papers)Yanhong Hou (1 shared paper)Song Liu (1 shared paper)Xi Chen (1 shared paper)Zibo Li (5 shared papers)Jacek Pinski (1 shared paper)Hong Shan (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Molecular Imaging and Biology (1 paper)Anticancer Research (1 paper)Blood (1 paper)Current Topics in Medicinal Chemistry (1 paper)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Peter Conti
23 papers receiving 471 citations
Peers
Comparison fields: 5 of 65
- Immunology and Allergy 95
- Radiology, Nuclear Medicine and Imaging 191
- Hematology 58
- Oncology 102
- Cancer Research 51
Countries citing papers authored by Peter Conti
This map shows the geographic impact of Peter Conti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Conti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Conti more than expected).
Fields of papers citing papers by Peter Conti
This network shows the impact of papers produced by Peter Conti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Conti. The network helps show where Peter Conti may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Conti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 194 | |
| 2 | 2002 | 78 | |
| 3 | 2011 | 62 | |
| 4 | 2003 | 34 | |
| 5 | 2013 | 29 | |
| 6 | 2014 | 20 | |
| 7 | 2015 | 20 | |
| 8 | 4-[125I] iodophenyltrimethylammonium ion, an iodinated acetylcholinesterase inhibitor with potential as a myocardial imaging agent. | 1980 | 14 |
| 9 | 2013 | 8 | |
| 10 | PET imaging of metabotropic glutamate receptor subtype 5 (mGluR5). | 2012 | 6 |
| 11 | 2020 | 4 | |
| 12 | Evaluation of 64Cu-labeled dipicolylamine (DPA) as a small-molecule PET probe for in vivo imaging of phosphatidylserine exposure | 2011 | 4 |
| 13 | Improved synthesis of 2′-deoxy-2′-[18F]fluoro-5-methyl-1-β-D-arabinofuranosyluracil (18F-FMAU) | 2010 | 3 |
| 14 | 2004 | 2 | |
| 15 | 2003 | 2 | |
| 16 | Safety outcomes and pain responses in the REASSURE observational study of radium-223 (Ra-223) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) | 2020 | 2 |
| 17 | 2008 | 2 | |
| 18 | 2012 | 1 | |
| 19 | 2017 | 1 | |
| 20 | Uncommon congenital abnormalities and PET-CT imaging | 2009 | 1 |
About Peter Conti
Peter Conti is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Molecular Biology, Oncology and Cancer Research, having authored 24 papers that have together received 490 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (11 papers), Medical Imaging Techniques and Applications (8 papers), Radiomics and Machine Learning in Medical Imaging (5 papers), Prostate Cancer Treatment and Research (4 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Glioma Diagnosis and Treatment (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Medical Imaging and Pathology Studies (2 papers). The work is most often cited by research in Immunology and Allergy (95 citations), Radiology, Nuclear Medicine and Imaging (191 citations), Hematology (58 citations), Oncology (102 citations) and Cancer Research (51 citations). Peter Conti has collaborated with scholars based in United States, China and Germany. Frequent co-authors include Hossein Jadvar, James R. Bading, Yanhong Hou, Song Liu, Xi Chen, Zibo Li, Jacek Pinski, Hong Shan, Dan Li and Kai Chen. Their work appears in journals such as Journal of Clinical Oncology, Molecular Imaging and Biology, Anticancer Research, Blood and Current Topics in Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.